Related Experiment Video
Updated: Oct 10, 2025
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
BACH2 inhibition reverses β cell failure in type 2 diabetes models
Jinsook Son1,2, Hongxu Ding3, Thomas B Farb4
1Department of Medicine and.
Abstract:
Type 2 diabetes (T2D) is associated with defective insulin secretion and reduced β cell mass. Available treatments provide a temporary reprieve, but secondary failure rates are high, making insulin supplementation necessary. Reversibility of β cell failure is a key translational question. Here, we reverse engineered and interrogated pancreatic islet-specific regulatory networks to discover T2D-specific subpopulations characterized by metabolic inflexibility and endocrine progenitor/stem cell features. Single-cell gain- and loss-of-function and glucose-induced Ca2+ flux analyses of top candidate master regulatory (MR) proteins in islet cells validated transcription factor BACH2 and associated epigenetic effectors as key drivers of T2D cell states. BACH2 knockout in T2D islets reversed cellular features of the disease, restoring a nondiabetic phenotype. BACH2-immunoreactive islet cells increased approximately 4-fold in diabetic patients, confirming the algorithmic prediction of clinically relevant subpopulations. Treatment with a BACH inhibitor lowered glycemia and increased plasma insulin levels in diabetic mice, and restored insulin secretion in diabetic mice and human islets. The findings suggest that T2D-specific populations of failing β cells can be reversed and indicate pathways for pharmacological intervention, including via BACH2 inhibition.
Insights
Researchers identified specific pancreatic beta cell populations in type 2 diabetes (T2D). Inhibiting the BACH2 protein reversed T2D cell features and improved insulin secretion, offering new therapeutic avenues for diabetes.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Type 2 diabetes (T2D) involves impaired insulin secretion and beta cell loss, with current treatments often leading to secondary failure.
- Reversing beta cell dysfunction is a critical goal for effective T2D management.
Purpose of the Study:
- To identify and characterize T2D-specific beta cell subpopulations.
- To uncover key regulatory networks driving T2D cellular states.
- To explore therapeutic strategies targeting identified pathways.
Main Methods:
- Computational analysis of pancreatic islet-specific regulatory networks.
- Single-cell gain- and loss-of-function studies.
- Analysis of glucose-induced calcium flux.
- BACH2 inhibition in preclinical models and human islets.
Main Results:
- Identified T2D-specific beta cell subpopulations with progenitor/stem cell features and metabolic inflexibility.
- Validated transcription factor BACH2 and associated epigenetic factors as key drivers of T2D cell states.
- BACH2 inhibition reversed T2D cellular phenotypes, lowered glycemia, and restored insulin secretion in mice and human islets.
- Observed a significant increase in BACH2-immunoreactive cells in diabetic patients.
Conclusions:
- T2D is characterized by distinct, reversibly failing beta cell populations.
- BACH2 is a critical regulator of T2D cell states and a potential therapeutic target.
- Targeting BACH2 offers a promising strategy for pharmacological intervention in type 2 diabetes.
Related Concept Videos
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:22Diabetes Mellitus: Type 2 and Gestational
01:05Insulin Secretory Vesicles
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:23Dipeptidyl Peptidase 4 Inhibitors
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...